One in Four Adults May Use Glp-1 Drugs This Year, Upending the Food Industry

Pharmalittle: We're reading about rising GLP-1 use, a psychedelic therapy for depression, and more

Delix Therapeutics, a drugmaker developing a psychedelic-like therapy to treat depression, reported positive results from an early trial

One in Four Adults May Use Glp-1 Drugs This Year, Upending the Food Industry

At this month’s Food and Nutrition Conference and Expo in Nashville, one buzzword dominated conversations – GLP-1 medications. From protein-packed bars, portion-controlled snacks to prepared meals, brands are racing to market foods for a rapidly growing segment, those taking popular…